title: Septic arthritis caused by Erysipelothrix rhusiopathiae infection after arthroscopically assisted anterior cruciate ligament reconstruction.
abstract: A case of septic arthritis caused by Erysipelothrix rhusiopathiae, after an arthroscopically assisted anterior cruciate ligament (ACL) substitution in a non-immunosuppressed patient is described. An 18-year-old man underwent an ACL reconstruction with a quadruple hamstring graft. Eight days postoperatively, the patient developed fever, knee pain, and effusion without erythema or suppuration. He was readmitted to the hospital with the diagnosis of septic arthritis. The patient's erythrocyte sedimentation rate, C-reactive protein level, and white blood cell count were high. The joint was aspirated and the fluid was sent for cultures that revealed the presence of E rhusiopathiae. E rhusiopathiae is widespread in nature, it is transmitted by direct cutaneous laceration, and it causes septic arthritis, meningitis, endocarditis, and renal failure in immunosuppressed people with poor prognosis. In our case, the infection was treated with arthroscopic lavage and debridement, retention of the graft and hardware, and intravenous antibiotic administration for 6 weeks, followed by oral administration for 16 weeks.
authors.affiliation: Sports Injuries Department, KAT Hospital, Athens, Greece. atilentzoglou@yahoo.com
authors.forename: Panagiotis G V
authors.initials: PG
authors.lastname: Allianatos
authors.forename: Anastasia C
authors.initials: AC
authors.lastname: Tilentzoglou
authors.forename: Alexander D
authors.initials: AD
authors.lastname: Koutsoukou
mesh_terms: D000293:Adolescent; D016118:Anterior Cruciate Ligament / Q000601:surgery*; D000070598:Anterior Cruciate Ligament Injuries; D001170:Arthritis, Infectious / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000601:surgery; D001182:Arthroscopy; D002939:Ciprofloxacin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004888:Erysipelothrix / Q000302:isolation & purification*; D004889:Erysipelothrix Infections / Q000097:blood / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D007718:Knee Injuries / Q000150:complications / Q000382:microbiology; D022125:Lacerations / Q000150:complications / Q000382:microbiology; D008297:Male; D010406:Penicillins / Q000627:therapeutic use; D012008:Recurrence; D012421:Rupture / Q000601:surgery; D012916:Soccer / Q000293:injuries; D013530:Surgical Wound Infection / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000601:surgery; D013582:Synovial Fluid / Q000382:microbiology; D017334:Teicoplanin / Q000627:therapeutic use; D007507:Therapeutic Irrigation
chemical_list: D010406:Penicillins; D002981:Clindamycin; D002939:Ciprofloxacin; D017334:Teicoplanin